Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-01-13 @ 5:50 PM
Study NCT ID:
NCT04786093
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-13
First Post:
2021-02-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Non-small cell lung cancer | View |
| None | Immunotherapy | View |
| None | Durvalumab | View |
| None | Radiation therapy | View |
| None | Radiotherapy | View |
| None | Stereotactic body radiation therapy | View |
| None | Stereotactic ablative radiotherapy | View |
| None | SBRT | View |
| None | SABR | View |
| None | PULSAR | View |